(Q51994323)

19 April 2018

title

The role of TCR stimulation and TGF-beta in controlling the expression of CD94/NKG2A receptors on CD8 T cells. (English)

1 reference

19 April 2018

author name string

Anasuya Gunturi

1

1 reference

19 April 2018

Rance E Berg

2

1 reference

19 April 2018

Emily Crossley

3

1 reference

19 April 2018

Sean Murray

4

1 reference

19 April 2018

James Forman

5

1 reference

19 April 2018

language of work or name

English

0 references

publication date

1 March 2005

1 reference

19 April 2018

European Journal of Immunology

published in

1 reference

19 April 2018

volume

35

1 reference

19 April 2018

issue

3

1 reference

19 April 2018

page(s)

766-775

1 reference

19 April 2018

Human CD94 Gene Expression: Dual Promoters Differing in Responsiveness to IL-2 or IL-15

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

Transcriptional Control of MurineCD94Gene: Differential Usage of Dual Promoters by Lymphoid Cell Types

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

Viral and bacterial infections induce expression of multiple NK cell receptors in responding CD8(+) T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

CD94/NKG2 expression does not inhibit cytotoxic function of lymphocytic choriomeningitis virus-specific CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

7 January 2021

Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

7 January 2021

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

7 January 2021

Identification of a tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

7 January 2021

Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

7 January 2021

Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

7 January 2021

Expression of killer inhibitory receptors on cytotoxic cells from HIV-1-infected individuals

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

7 January 2021

NK-associated receptors on CD8 T cells from treatment-naive HIV-infected individuals: defective expression of CD56

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

7 January 2021

TCR specificity dictates CD94/NKG2A expression by human CTL.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

7 January 2021

Preferential survival of CD8 T and NK cells expressing high levels of CD94

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

7 January 2021

CD94-NKG2A receptors regulate antiviral CD8(+) T cell responses.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

7 January 2021

HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

7 January 2021

Expression of CD94/NKG2-A on human T lymphocytes is induced by IL-12: implications for adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

7 January 2021

Transforming growth factor-beta-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

7 January 2021

Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

7 January 2021

Transforming growth factor-beta is a potent negative regulator of human lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

7 January 2021

Transforming growth factor-beta: an important mediator of immunoregulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

7 January 2021

Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

7 January 2021

Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

7 January 2021

Implications of CD94 deficiency and monoallelic NKG2A expression for natural killer cell development and repertoire formation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

7 January 2021

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

7 January 2021

IL-7 is critical for homeostatic proliferation and survival of naive T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

7 January 2021

NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

7 January 2021

Cloning of murine NKG2A, B and C: second family of C-type lectin receptors on murine NK cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

7 January 2021

DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

7 January 2021

Synergistic activation of transcription by physiologically unrelated transcription factors through cooperative DNA-binding

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

7 January 2021

Evidence for two modes of cooperative DNA binding in vivo that do not involve direct protein-protein interactions

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

7 January 2021

Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

7 January 2021

Human Smad3 and Smad4 are sequence-specific transcription activators

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

7 January 2021

C-type lectin-like receptors in peptide-specific HLA class I-restricted cytotoxic T lymphocytes: differential expression and modulation of effector functions in clones sharing identical TCR structure and epitope specificity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

7 January 2021

In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

7 January 2021

Production of transforming growth factor beta by human peripheral blood monocytes and neutrophils

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

7 January 2021

Expression of transforming growth factor type beta on human epidermal dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

7 January 2021

Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425735

7 January 2021

Identifiers

DOI

10.1002/EJI.200425735

1 reference

19 April 2018

PubMed ID

15714583

1 reference

19 April 2018